These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 27755104)

  • 1. LILRA3 deletion is a genetic risk factor of HIV infection.
    Ahrenstorf G; Low HZ; Kniesch K; Ordonez D; Meyer-Olson D; Ahmad F; Kücherer C; Gunsenheimer-Bartmeyer B; Stoll M; Matthias T; Schmidt RE; Witte T
    AIDS; 2017 Jan; 31(1):25-34. PubMed ID: 27755104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
    Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
    Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.
    An H; Lim C; Guillemin GJ; Vollmer-Conna U; Rawlinson W; Bryant K; Tedla N
    PLoS One; 2016; 11(2):e0149200. PubMed ID: 26871720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR8 regulation of LILRA3 in monocytes is abrogated in human immunodeficiency virus infection and correlates to CD4 counts and virus loads.
    Low HZ; Ahrenstorf G; Pommerenke C; Habermann N; Schughart K; Ordóñez D; Stripecke R; Wilk E; Witte T
    Retrovirology; 2016 Mar; 13():15. PubMed ID: 26969150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Leukocyte Immunoglobulin-like Receptor A3 Gene With Neutrophil Activation and Disease Susceptibility in Adult-Onset Still's Disease.
    Wang M; Liu M; Jia J; Shi H; Teng J; Liu H; Sun Y; Cheng X; Ye J; Su Y; Chi H; Liu T; Wang Z; Wan L; Meng J; Ma Y; Yang C; Hu Q
    Arthritis Rheumatol; 2021 Jun; 73(6):1033-1043. PubMed ID: 33381895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble LILRA3, a potential natural antiinflammatory protein, is increased in patients with rheumatoid arthritis and is tightly regulated by interleukin 10, tumor necrosis factor-alpha, and interferon-gamma.
    An H; Chandra V; Piraino B; Borges L; Geczy C; McNeil HP; Bryant K; Tedla N
    J Rheumatol; 2010 Aug; 37(8):1596-606. PubMed ID: 20595277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's Syndrome.
    Argyriou E; Nezos A; Roussos P; Venetsanopoulou A; Voulgarelis M; Boki K; Tzioufas AG; Moutsopoulos HM; Mavragani CP
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33567548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte immunoglobulin-like receptor A3 gene deletion in five Chinese populations and protective association with nasopharyngeal carcinoma.
    Tian W; Li LX; Cheng W; Jin HK; Zhang SS
    Int J Immunogenet; 2024 Feb; 51(1):32-38. PubMed ID: 38015196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6.7-kbp deletion in LILRA3 (ILT6) gene is associated with later onset of the multiple sclerosis in a Polish population.
    Wiśniewski A; Wagner M; Nowak I; Bilińska M; Pokryszko-Dragan A; Jasek M; Kuśnierczyk P
    Hum Immunol; 2013 Mar; 74(3):353-7. PubMed ID: 23238213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of LILRA3 (ILT6/LIR4) deletion in psoriatic patients and healthy controls.
    Wiśniewski A; Łuszczek W; Mańczak M; Jasek M; Kubicka W; Cislo M; Kuśnierczyk P
    Hum Immunol; 2003 Apr; 64(4):458-61. PubMed ID: 12651072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis.
    Ortiz MA; Núñez C; Ordóñez D; Alvarez-Cermeño JC; Martínez-Rodriguez JE; Sánchez AJ; Arroyo R; Izquierdo G; Malhotra S; Montalban X; García-Merino A; Munteis E; Alcina A; Comabella M; Matesanz F; Villar LM; Urcelay E
    PLoS One; 2015; 10(8):e0134414. PubMed ID: 26274821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequencies of the
    Wang H; Wang Y; Tang Y; Ye H; Zhang X; Zhou G; Lv J; Cai Y; Li Z; Guo J; Wang Q
    Front Genet; 2019; 10():869. PubMed ID: 31620171
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple sclerosis associates with LILRA3 deletion in Spanish patients.
    Ordóñez D; Sánchez AJ; Martínez-Rodríguez JE; Cisneros E; Ramil E; Romo N; Moraru M; Munteis E; López-Botet M; Roquer J; García-Merino A; Vilches C
    Genes Immun; 2009 Sep; 10(6):579-85. PubMed ID: 19421224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA sequence variation and molecular genotyping of natural killer leukocyte immunoglobulin-like receptor, LILRA3.
    Norman PJ; Carey BS; Stephens HAF; Vaughan RW
    Immunogenetics; 2003 Jun; 55(3):165-171. PubMed ID: 12750859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition.
    Márquez A; Fernández-Aranguren T; Witte T; González-Gay MA; Martín J; ;
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):208-209. PubMed ID: 27462831
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of the LILRA3 deletion with B-NHL and functional characterization of the immunostimulatory molecule.
    Low HZ; Reuter S; Topperwien M; Dankenbrink N; Peest D; Kabalak G; Stripecke R; Schmidt RE; Matthias T; Witte T
    PLoS One; 2013; 8(12):e81360. PubMed ID: 24363809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte immunoglobulin-like receptor A3 is increased in IBD patients and functions as an anti-inflammatory modulator.
    Lan X; Liu F; Ma J; Chang Y; Lan X; Xiang L; Shen X; Zhou F; Zhao Q
    Clin Exp Immunol; 2021 Feb; 203(2):286-303. PubMed ID: 33006756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
    Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
    J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term persistence of both functional and non-functional alleles at the leukocyte immunoglobulin-like receptor A3 (LILRA3) locus suggests balancing selection.
    Hirayasu K; Ohashi J; Kashiwase K; Takanashi M; Satake M; Tokunaga K; Yabe T
    Hum Genet; 2006 May; 119(4):436-43. PubMed ID: 16501917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated expression of leukocyte immunoglobulin-like receptor A3 in patients with severe aplastic anemia.
    Yu H; Liu H; Zhao Y; Wang H; Liu C; Qi W; Liu Z; Sun Y; Gao S; Tao J; Fu R; Shao Z
    Exp Ther Med; 2021 Apr; 21(4):346. PubMed ID: 33732319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.